Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 c » 50 _ (Expand Search), 50 μ (Expand Search), 5 c (Expand Search)
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2.
Published 2013“…Nude mice (7 per group) were s.c. injected with 1×10<sup>6</sup> CNDT 2.5 cells. Mice with visible tumors were stratified and treated with 5 µg of liposome-conjugated siRNA (i.p. injections) twice weekly. …”
-
110
Adaptation to cool temperature decreases basal and stimulated lipolysis and increases <i>de novo</i> lipogenesis and TAG synthesis.
Published 2021“…Rapid reduction of β3- and β2-adrenergic receptor mRNAs after exposure to 31°C (<i>n</i> = 6 per time point). Gene expression was normalized to geometric mean of <i>Hprt</i>, <i>Tbp</i>, and <i>Ppia</i> and is expressed relative to 37°C control (<i>n</i> = 4). …”
-
111
-
112
Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4<sup>+</sup> T cells.
Published 2016“…<p>(A) Representative flow cytometric analysis of the proportion of CCR6 (left) and CXCR3 (right) expressing CD4<sup>+</sup> T cells stimulated with (grey) or without (open) anti-CD3/CD28 for 72 hours. (B–C) The proportion of CCR6 expressing cells at day 3 (left) and day 5 (right) under normoxia (black bars) and hypoxia (grey bars) in the presence (+) and absence (-) of 25 μM BPTES and 50 μM 968. …”
-
113
-
114
-
115
Eltrombopag markedly decreases levels of ROS in MOLM14 cells.
Published 2015“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
-
116
-
117
-
118
-
119
-
120